• Relay Medical (RELA) and Fio will provide rapid COVID-19 testing at the Toronto International Film Festival
  • Masks will be mandatory for anyone attending in-person screenings, and talent and media personnel will be tested regularly
  • TIFF executives and others attending events will need to be tested every 48 hours, and out-of-country visitors will be tested within 72 hours of arriving in Toronto
  • The Fionet Platform is an end-to-end, rapid testing and tracking solution that enhances the quality of healthcare delivered in decentralized settings
  • Relay Medical is a technology innovator focused on the development of novel solutions in the diagnostics, AI data science and IoT security sectors
  • Relay Medical Corp. (RELA) is down 4.26 per cent, trading at C$0.225 per share at 4:30 pm ET

Relay Medical (RELA) and Fio, through Fionet Rapid Response Group, will provide rapid COVID-19 testing at the Toronto International Film Festival (TIFF).

The 46th edition of the Toronto International Film Festival features 10 days of international and Canadian cinema with close to 200 films, featuring acclaimed industry guests, and TIFF’s Industry Conference.

“The Toronto International Film Festival is a premiere event for the city of Toronto, and we are proud to do our part to keep attendees as safe as possible in these challenging times,” said Yoav Raiter, CEO Relay Medical Corp.

“Our recent success at the National Bank Open tennis tournament and 2021 FIFA Qualifying Games have shown how quick, easy, and effective our rapid diagnostic testing platform performs. We are very much looking forward to another successful festival and welcome the visiting movie stars from around the world.”

Masks will be mandatory for anyone attending in-person screenings, and talent and media personnel will be tested regularly. Organizers also said that actors, filmmakers, TIFF executives and others attending events will need to be tested for COVID-19 every 48 hours, in addition to out-of-country visitors being tested within 72 hours of arriving in Toronto.

The Fionet Platform is a rapid testing and tracking solution for community-based settings. The platform can manage scheduling and registration through the phone app at home, on-site check-in, on-the-spot antigen testing, data integration with other testing devices and provide result notifications, among others.

Relay Medical is a technology innovator focused on the development of novel solutions in the diagnostics, AI data science and IoT security sectors.

Relay Medical Corp. (RELA) is down 4.26 per cent, trading at C$0.225 per share at 4:30 pm ET.

More From The Market Online

Usha Resources begins phase 4 fieldwork at White Willow Project

Usha Resources (TSXV:USHA) has begun the fourth phase of fieldwork at its White Willow Lithium Project in Ontario following phase 3 work.

@ the Bell: Stocks level-out ahead of Easter long weekend

A rebound in oil prices and growth in metal prices helped push Canada’s main stock index higher as investors await economic data.